Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells

A significant proportion of men diagnosed with prostate cancer (PCa) eventually develop metastatic disease, which progresses to castration resistance, despite initial response to androgen deprivation. As anticancer therapy has become increasingly effective, acquired drug resistance has emerged, limi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cell Mol Med
Main Authors: Tsaur, Igor, Hudak, Lukasz, Makarević, Jasmina, Juengel, Eva, Mani, Jens, Borgmann, Hendrik, Gust, Kilian M, Schilling, David, Bartsch, Georg, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4549030/
https://ncbi.nlm.nih.gov/pubmed/25808196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12583
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados